# Supernus Pharmaceuticals, Inc.: Form 8-K, filed Jun 17, 2025

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: 8-K
- Filed: 2025-06-17
- Accepted by EDGAR: Jun 17, 2025, 16:40 ET
- Period: 2025-06-16
- Accession: 0001356576-25-000042
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000042/supn-20250616.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000042/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000135657625000042/supn-20250616.htm

Filed Jun 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001356576-25-000042. Last ingested by Listed: Nov 12, 2026, 17:12 ET. No prices; not investment advice.
